Chapter 1 Biologics and Biosimilars Market Overview
1.1 Biologics and Biosimilars Definition
1.2 Global Biologics and Biosimilars Market Size Status and Outlook (2017-2031)
1.3 Global Biologics and Biosimilars Market Size Comparison by Region (2017-2031)
1.4 Global Biologics and Biosimilars Market Size Comparison by Type (2017-2031)
1.5 Global Biologics and Biosimilars Market Size Comparison by Application (2017-2031)
1.6 Global Biologics and Biosimilars Market Size Comparison by Sales Channel (2017-2031)
1.7 Biologics and Biosimilars Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 Biologics and Biosimilars Market Segment Analysis by Player
2.1 Global Biologics and Biosimilars Sales and Market Share by Player (2020-2022)
2.2 Global Biologics and Biosimilars Revenue and Market Share by Player (2020-2022)
2.3 Global Biologics and Biosimilars Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biologics and Biosimilars Market Segment Analysis by Type
3.1 Global Biologics and Biosimilars Market by Type
3.1.1 Monoclonal Antibodies
3.1.2 Interferon
3.1.3 Erythropoietin
3.1.4 Insulin
3.1.5 Vaccines
3.2 Global Biologics and Biosimilars Sales and Market Share by Type (2017-2022)
3.3 Global Biologics and Biosimilars Revenue and Market Share by Type (2017-2022)
3.4 Global Biologics and Biosimilars Average Price by Type (2017-2022)
3.5 Leading Players of Biologics and Biosimilars by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 Biologics and Biosimilars Market Segment Analysis by Application
4.1 Global Biologics and Biosimilars Market by Application
4.1.1 Tumor
4.1.2 Diabetes
4.1.3 Cardiovascular
4.1.4 Hemophilia
4.1.5 Other
4.2 Global Biologics and Biosimilars Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of Biologics and Biosimilars by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 Biologics and Biosimilars Market Segment Analysis by Sales Channel
5.1 Global Biologics and Biosimilars Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biologics and Biosimilars Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biologics and Biosimilars Market Segment Analysis by Region
6.1 Global Biologics and Biosimilars Market Size and CAGR by Region (2017-2031)
6.2 Global Biologics and Biosimilars Sales and Market Share by Region (2017-2022)
6.3 Global Biologics and Biosimilars Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biologics and Biosimilars Market Share by Type
6.4.3 North America Biologics and Biosimilars Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biologics and Biosimilars Market Share by Type
6.5.3 Europe Biologics and Biosimilars Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biologics and Biosimilars Market Share by Type
6.6.3 Asia-Pacific Biologics and Biosimilars Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biologics and Biosimilars Market Share by Type
6.7.3 South America Biologics and Biosimilars Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biologics and Biosimilars Market Share by Type
6.8.3 Middle East & Africa Biologics and Biosimilars Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biologics and Biosimilars Players
7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Amgen
7.3 AbbVie
7.4 Sanofi-Aventis
7.5 Johnson & Johnson
7.6 Pfizer
7.7 Novo Nordisk
7.8 Eli Lilly
7.9 Novartis
7.10 Merck
7.11 3sbio
7.12 Changchun High Tech
7.13 CP Guojian
7.14 Biotech
7.15 Gelgen
7.16 Innovent
7.17 Dong Bao
7.18 Ganlee
Chapter 8 Upstream and Downstream Analysis of Biologics and Biosimilars
8.1 Industrial Chain of Biologics and Biosimilars
8.2 Upstream of Biologics and Biosimilars
8.3 Downstream of Biologics and Biosimilars
Chapter 9 Development Trend of Biologics and Biosimilars (2023-2031)
9.1 Global Biologics and Biosimilars Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
